Galmed Pharmaceuticals (Israel)

Recent papers from Galmed Pharmaceuticals (Israel)

1. Topological Engineering of Metal–Organic Architectures for Tunable Ultrafast Nonlinear Optical ResponsesAdvanced Optical Materials · 2026
2. AI-Assisted Dismantling of Electric Vehicle Batteries – A Case Study on Technology NetworkingProcedia Computer Science · 2026
3. In‐Operando 4D‐STEM and STEM‐EBIC Imaging of Electric Fields and Charge Carrier Behavior in Biased Silicon p–n JunctionsAdvanced Electronic Materials · 2026
4. The SCD1 inhibitor aramchol interacts with regorafenib to kill GI tumor cells in vitro and in vivoOncotarget · 2025
5. Aramchol improves hepatic fibrosis in metabolic dysfunction–associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathologyHepatology · 2024
6. A framework for the detection and attribution of biodiversity changePhilosophical Transactions of the Royal Society B Biological Sciences · 2023
7. Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional studyWorld Journal of Urology · 2022
8. Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profilesHepatology · 2022
9. Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesisJHEP Reports · 2021
10. Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer’s disease-like pathologyAlzheimer s Research & Therapy · 2020
11. See (n)One, Do (n)One, Teach (n)One: Reality of Surgical Resident Training in GermanyWorld Journal of Surgery · 2020
12. Role of aramchol in steatohepatitis and fibrosis in miceHepatology Communications · 2017
13. Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMSJournal of Neuroinflammation · 2017